factual

Mammography shows no all-cause mortality benefit

Pooling all the mammographic screening randomized trials, there is no all-cause mortality signal (effect size around 0.99, confidence interval crossing one); proponents argue the trials are underpowered and that perhaps 3 million women would need to be randomized to detect an effect, but if the effect is that small it may not justify a $100-billion campaign.

factualpending

Speaker

Vinay Prasad

Evidence Quote

“You'd probably need, like, 3 million women randomized and there are usually in the tens of thousands... if you need 3 million women randomized to see the effect, maybe it's a small effect.”

Source

Vinay Prasad on Cancer Screening— EconTalk
Created: 6/13/2026, 12:15:40 AM

Your notes

Loading notes...